Corvus Pharmaceuticals, Inc. Quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent in pure for Q4 2017
-
Taxonomy & unit
-
us-gaap: pure
-
Description
-
Percentage of domestic federal statutory tax rate applicable to pretax income (loss).
-
Summary
-
Corvus Pharmaceuticals, Inc. annual/quarterly Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent history and growth rate for Q4 2017.
- Corvus Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for the quarter ending January 1, 2018 was 0.21 pure.
- Corvus Pharmaceuticals, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2023 was 0.21 pure, unchanged from 2022.
- Corvus Pharmaceuticals, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2022 was 0.21 pure, unchanged from 2021.
- Corvus Pharmaceuticals, Inc. annual Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent for 2021 was 0.21 pure, unchanged from 2020.
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent, Quarterly (pure)